According to a recent LinkedIn post from ABM Respiratory Care, the company is exhibiting at the Sunshine State Seminar in Daytona Beach Shores, Florida, on March 25–26. The post highlights in-person demonstrations of its BiWaze Cough and BiWaze Clear airway clearance systems, positioned as supporting patients across hospital and home settings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post suggests a focus on differentiating the BiWaze platform through technical features such as a dual blower system enabling bi-directional control of inhalation and exhalation, and a closed breathing circuit aimed at mucus mobilization and aerosol deposition. For investors, this type of clinical-education presence may help drive brand awareness among respiratory therapists, support adoption in respiratory care pathways, and potentially strengthen ABM Respiratory Care’s competitive position in the airway clearance device market.
By emphasizing new clinical studies in the seminar messaging, the post indicates an effort to link product capabilities with emerging evidence, which could be important for hospital procurement decisions and reimbursement discussions. While the post does not disclose commercial metrics, participating in a targeted professional event and offering remote demos may contribute to lead generation, pipeline development, and longer-term revenue opportunities if clinical and economic benefits are validated and recognized by providers.